<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MedAI: Evaluating TxAgent's Therapeutic Agentic Reasoning in the NeurIPS CURE-Bench Competition - Health AI Hub</title>
    <meta name="description" content="This paper introduces MedAI's TxAgent, an agentic AI system leveraging a fine-tuned Llama-3.1-8B model with iterative retrieval-augmented generation (RAG) for t">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>MedAI: Evaluating TxAgent's Therapeutic Agentic Reasoning in the NeurIPS CURE-Bench Competition</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.11682v1" target="_blank">2512.11682v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-12
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Tim Cofala, Christian Kalfar, Jingge Xiao, Johanna Schrader, Michelle Tang, Wolfgang Nejdl
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.11682v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.11682v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces MedAI's TxAgent, an agentic AI system leveraging a fine-tuned Llama-3.1-8B model with iterative retrieval-augmented generation (RAG) for therapeutic decision-making by dynamically integrating biomedical tool calls. Their participation in the NeurIPS CURE-Bench Challenge demonstrated that retrieval quality for function calls significantly influences overall model performance, with improved tool-retrieval strategies yielding notable performance gains. The work was awarded the Excellence Award in Open Science for its contribution to robust, multi-step reasoning in clinical medicine.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to clinical medicine by advancing AI systems capable of robust, multi-step reasoning for critical tasks like accurate drug recommendation, personalized treatment planning, and precise adverse-effect prediction. It directly addresses the need for safer and more effective AI guidance in complex, high-stakes clinical decision-making.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes TxAgent, an agentic AI system leveraging a fine-tuned Llama-3.1-8B model and Retrieval-Augmented Generation (RAG) to provide therapeutic agentic reasoning. It is designed for applications like drug recommendation, treatment planning, and adverse-effect prediction by dynamically interacting with a unified biomedical tool suite (e.g., FDA Drug API, OpenTargets, Monarch resources) to assist with complex clinical decision-making.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>TxAgent is an agentic AI method designed for high-stakes therapeutic decision-making tasks, including drug recommendation, treatment planning, and adverse-effect prediction.</li>
                    
                    <li>The system employs an iterative Retrieval-Augmented Generation (RAG) architecture, powered by a fine-tuned Llama-3.1-8B model.</li>
                    
                    <li>TxAgent dynamically generates and executes function calls to ToolUniverse, a unified biomedical tool suite integrating FDA Drug API, OpenTargets, and Monarch resources for current therapeutic information.</li>
                    
                    <li>The research emphasizes the critical importance of accuracy in both the AI's reasoning trace and its sequence of tool invocations due to stringent safety constraints in medical applications.</li>
                    
                    <li>Evaluation was conducted within the NeurIPS CURE-Bench 2025 Challenge, which benchmarks therapeutic-reasoning systems using metrics for correctness, tool utilization, and reasoning quality.</li>
                    
                    <li>The study specifically analyzes and highlights how the retrieval quality for function (tool) calls directly influences the overall performance of the model.</li>
                    
                    <li>Demonstrated performance gains were achieved through the implementation of improved tool-retrieval strategies, underscoring the practical impact of this aspect.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology centers on TxAgent, an agentic AI system built upon a fine-tuned Llama-3.1-8B model, utilizing an iterative Retrieval-Augmented Generation (RAG) framework. The core mechanism involves dynamically generating and executing function calls to ToolUniverse, a comprehensive biomedical tool suite that integrates FDA Drug API, OpenTargets, and Monarch. The system's performance was rigorously evaluated against the NeurIPS CURE-Bench 2025 Challenge metrics, which assess correctness, tool utilization, and reasoning quality, with a particular focus on analyzing and optimizing tool-retrieval strategies.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary findings indicate that TxAgent successfully applies agentic AI and iterative RAG for complex therapeutic reasoning, demonstrating effective performance within the CURE-Bench Challenge framework. A crucial discovery is the direct and significant influence of function (tool) call retrieval quality on the overall model's performance. Furthermore, the research explicitly shows that implementing improved strategies for tool retrieval leads to demonstrable and tangible performance gains in therapeutic decision-making tasks.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This work has significant potential for clinical impact by enabling more accurate, reliable, and safer AI guidance in therapeutic decision-making. It could lead to enhanced drug recommendation systems, more precise and personalized treatment plans, and earlier, more accurate prediction of adverse drug effects, ultimately improving patient outcomes, reducing medical errors, and optimizing clinical workflows.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations of TxAgent or the current study. However, it implicitly highlights the inherent "stringent safety constraints" in medical AI applications, suggesting that achieving absolute reliability and full clinical readiness for high-stakes deployment remains an ongoing challenge.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly outline future research directions. However, the emphasis on "stringent safety constraints" and continuous improvements in tool-retrieval strategies implies ongoing efforts to enhance the robustness, interpretability, and safety of agentic AI systems for seamless and trustworthy integration into clinical practice.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Clinical Pharmacology</span>
                    
                    <span class="tag">Medical Informatics</span>
                    
                    <span class="tag">Drug Discovery and Development</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Clinical Decision Support</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">TxAgent</span>
                    
                    <span class="tag tag-keyword">Agentic AI</span>
                    
                    <span class="tag tag-keyword">RAG</span>
                    
                    <span class="tag tag-keyword">Llama-3.1-8B</span>
                    
                    <span class="tag tag-keyword">CURE-Bench</span>
                    
                    <span class="tag tag-keyword">Therapeutic Reasoning</span>
                    
                    <span class="tag tag-keyword">Drug Recommendation</span>
                    
                    <span class="tag tag-keyword">Clinical Decision Support</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Therapeutic decision-making in clinical medicine constitutes a high-stakes domain in which AI guidance interacts with complex interactions among patient characteristics, disease processes, and pharmacological agents. Tasks such as drug recommendation, treatment planning, and adverse-effect prediction demand robust, multi-step reasoning grounded in reliable biomedical knowledge. Agentic AI methods, exemplified by TxAgent, address these challenges through iterative retrieval-augmented generation (RAG). TxAgent employs a fine-tuned Llama-3.1-8B model that dynamically generates and executes function calls to a unified biomedical tool suite (ToolUniverse), integrating FDA Drug API, OpenTargets, and Monarch resources to ensure access to current therapeutic information. In contrast to general-purpose RAG systems, medical applications impose stringent safety constraints, rendering the accuracy of both the reasoning trace and the sequence of tool invocations critical. These considerations motivate evaluation protocols treating token-level reasoning and tool-usage behaviors as explicit supervision signals. This work presents insights derived from our participation in the CURE-Bench NeurIPS 2025 Challenge, which benchmarks therapeutic-reasoning systems using metrics that assess correctness, tool utilization, and reasoning quality. We analyze how retrieval quality for function (tool) calls influences overall model performance and demonstrate performance gains achieved through improved tool-retrieval strategies. Our work was awarded the Excellence Award in Open Science. Complete information can be found at https://curebench.ai/.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>7 pages, 3 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>